These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22960547)

  • 1. Amniotic fluid stem cells to study mTOR signaling in differentiation.
    Rosner M; Schipany K; Shanmugasundaram B; Lubec G; Brandau O; Hengstschläger M
    Organogenesis; 2012; 8(3):96-100. PubMed ID: 22960547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of mTOR pathway proteins in human amniotic fluid stem cells.
    Siegel N; Valli A; Fuchs C; Rosner M; Hengstschläger M
    Int J Mol Med; 2009 Jun; 23(6):779-84. PubMed ID: 19424604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An emerging role for TOR signaling in mammalian tissue and stem cell physiology.
    Russell RC; Fang C; Guan KL
    Development; 2011 Aug; 138(16):3343-56. PubMed ID: 21791526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Embryoid body formation of human amniotic fluid stem cells depends on mTOR.
    Valli A; Rosner M; Fuchs C; Siegel N; Bishop CE; Dolznig H; Mädel U; Feichtinger W; Atala A; Hengstschläger M
    Oncogene; 2010 Feb; 29(7):966-77. PubMed ID: 19935716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberin and PRAS40 are anti-apoptotic gatekeepers during early human amniotic fluid stem-cell differentiation.
    Fuchs C; Rosner M; Dolznig H; Mikula M; Kramer N; Hengstschläger M
    Hum Mol Genet; 2012 Mar; 21(5):1049-61. PubMed ID: 22090422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of human amniotic fluid stem cells to renal tissue formation depends on mTOR.
    Siegel N; Rosner M; Unbekandt M; Fuchs C; Slabina N; Dolznig H; Davies JA; Lubec G; Hengstschläger M
    Hum Mol Genet; 2010 Sep; 19(17):3320-31. PubMed ID: 20542987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From growing to secreting: new roles for mTOR in aging cells.
    Pani G
    Cell Cycle; 2011 Aug; 10(15):2450-3. PubMed ID: 21720215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mTOR signaling in growth control and disease.
    Laplante M; Sabatini DM
    Cell; 2012 Apr; 149(2):274-93. PubMed ID: 22500797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTOR Signaling at the Crossroad between Metazoan Regeneration and Human Diseases.
    Lund-Ricard Y; Cormier P; Morales J; Boutet A
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32295297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coordinated time-dependent modulation of AMPK/Akt/mTOR signaling and autophagy controls osteogenic differentiation of human mesenchymal stem cells.
    Pantovic A; Krstic A; Janjetovic K; Kocic J; Harhaji-Trajkovic L; Bugarski D; Trajkovic V
    Bone; 2013 Jan; 52(1):524-31. PubMed ID: 23111315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S6K Promotes Dopaminergic Neuronal Differentiation Through PI3K/Akt/mTOR-Dependent Signaling Pathways in Human Neural Stem Cells.
    Lee JE; Lim MS; Park JH; Park CH; Koh HC
    Mol Neurobiol; 2016 Aug; 53(6):3771-3782. PubMed ID: 26143260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mTOR signaling in stem and progenitor cells.
    Meng D; Frank AR; Jewell JL
    Development; 2018 Jan; 145(1):. PubMed ID: 29311260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p62 Promotes Amino Acid Sensitivity of mTOR Pathway and Hepatic Differentiation in Adult Liver Stem/Progenitor Cells.
    Sugiyama M; Yoshizumi T; Yoshida Y; Bekki Y; Matsumoto Y; Yoshiya S; Toshima T; Ikegami T; Itoh S; Harimoto N; Okano S; Soejima Y; Shirabe K; Maehara Y
    J Cell Physiol; 2017 Aug; 232(8):2112-2124. PubMed ID: 27748507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human amniotic fluid stem cells as a model for functional studies of genes involved in human genetic diseases or oncogenesis.
    Rosner M; Dolznig H; Schipany K; Mikula M; Brandau O; Hengstschläger M
    Oncotarget; 2011 Sep; 2(9):705-12. PubMed ID: 21926447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTOR signaling plays a critical role in the defects observed in muscle-derived stem/progenitor cells isolated from a murine model of accelerated aging.
    Takayama K; Kawakami Y; Lavasani M; Mu X; Cummins JH; Yurube T; Kuroda R; Kurosaka M; Fu FH; Robbins PD; Niedernhofer LJ; Huard J
    J Orthop Res; 2017 Jul; 35(7):1375-1382. PubMed ID: 27572850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD117(+) amniotic fluid stem cells: state of the art and future perspectives.
    Cananzi M; De Coppi P
    Organogenesis; 2012; 8(3):77-88. PubMed ID: 23037870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of amniotic fluid stem cells in basic science and tissue regeneration.
    Klemmt P
    Organogenesis; 2012; 8(3):76. PubMed ID: 23187723
    [No Abstract]   [Full Text] [Related]  

  • 18. Human amniotic fluid stem cells: a new perspective.
    Siegel N; Rosner M; Hanneder M; Freilinger A; Hengstschläger M
    Amino Acids; 2008 Aug; 35(2):291-3. PubMed ID: 17710362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing stemness and neural commitment in human amniotic fluid cells.
    Jezierski A; Gruslin A; Tremblay R; Ly D; Smith C; Turksen K; Sikorska M; Bani-Yaghoub M
    Stem Cell Rev Rep; 2010 Jun; 6(2):199-214. PubMed ID: 20221716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital anomalies: treatment options based on amniotic fluid-derived stem cells.
    Kunisaki SM
    Organogenesis; 2012; 8(3):89-95. PubMed ID: 22986340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.